H.C. Wainwright Reiterates Buy Rating on Microbot Medical (MBOT)

April 14, 2026 6:52 AM

H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $12.00 price target on Microbot Medical (NASDAQ: MBOT).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found